The Lung Cancer Research Foundation (LCRF) announces the first recipients of its LCRF Team Science Award on Advancing Therapies Toward Curing EGFR Mutated Lung Cancers. The project, "A novel ...

In this segment on advanced renal cell carcinoma, Dr. Geynisman raises the increasingly relevant question of how prior ...

Neeraj Agarwal and Tanya Dorff discuss the expanding role of PARP inhibitors in prostate cancer treatment. Both clinicians emphasize conducting next-generation sequencing testing earlier in metastatic ...

Three-color combinations have also been around since the beginning, and only received lore-friendly naming conventions for the five Allied-color combinations with Shards of Alara (2008), and the five ...

New immunotherapy drug combinations are significantly extending survival for patients with advanced kidney cancer, one of the fastest-growing cancers in the United States, according to oncologists and ...

Positive results from Phase 3 HERIZON-GEA-01 results support Ziihera as the HER2-targeted agent-of-choice in HER2+ first-line metastatic GEA and Ziihera plus chemotherapy to replace trastuzumab as the ...

VANCOUVER, British Columbia, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse ...

DUBLIN, Jan. 6, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive efficacy and safety results from the Phase 3 HERIZON-GEA-01 trial evaluating Ziihera ® ...